blue cross blue shield not covering glp 1 GLP-1 Drugs Could Raise Employer Health Premiums MCT2D | 2023 Updates to

Mayo Clinics ENDO 2025 finding (tirzepatide plus HRT produces ~35% more weight loss than tirzepatide alone) is why hormonal context belongs in every program-choice conversation for women over 40

However, real-world use reveals higher reported anxiety incidence in some populations, suggesting trial populations may not fully represent all users or that symptom severity goes underreported in structured settings

The recommended intake is 1.2 to 1.6 grams of protein per kilogram of body weight daily

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

Back Thorens, B, Porret, A, Bhler, L, et al (Nov 1993) Cloning and functional expression of the human islet GLP-1 receptor

5 Likes KarlT February 20, 2023, 7:58am #7 I think the concern is that the percent of muscle loss is considerably higher when using this drug